There's obviously another $50m USD under DD from the deal linked...

There's obviously another $50m USD under DD from the deal linked below - going back to August last year, and also mentioned in the cap raise pres:

"Under the terms of the agreement, the funds managed by Carlyle and Abingworth, in collaboration with Launch Tx, will commit US$120 million in three installments at fixed time points and retain an option to commit another US$50 million, representing total funding of up to US$170 million for Opthea."

https://www.carlyle.com/media-room/...and Boston, MA,US$170 million from investment

If they take up that option it is good news in two ways - 1. They have determined that the likely commercial outcome is favorable, after considerable DD!, and 2. Opthea gets past the topline data deadline without diluting shareholders.

It might make sense that the new management team, and the recent cap raise have ticked some boxes! (I would understand they don't want to fund without getting to the next binary. They may also have been (even if not directly impacted) unimpressed with the long wait for a dilutive raise at a low price, which might demonstrate some distraction while dealing with the critical scientific/technical aspects by the previous CEO, over a management focus on the whole business.

Just my thoughts anyway FWIW